About Illumi Medical
Illumi Medical is a company based in Nagoya (Japan) founded in 2023. Illumi Medical has raised $9.13 million across 4 funding rounds from investors including Ogaki Kyoritsu Bank, UntroD and UntroD. Illumi Medical operates in a competitive market with competitors including PhotoPharmics, CranioVation, Adgero Biopharma, Lumeda and SpectraCure, among others.
- Headquarter Nagoya, Japan
- SectorsHealthcare
- Website illumimedical.com
- Total Equity Funding$9.13M (USD)
in 4 rounds
- Latest Funding Round$3.44M (USD), Series A
Apr 2026
- InvestorsOgaki Kyoritsu Bank
& 12 more
Funding Insights of Illumi Medical
Illumi Medical has successfully raised a total of $9.13M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3.44 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.13M
- Total Rounds 4
- Last Round Series A — $3.44M
- Investors Count 13
All 4 funding rounds of Illumi Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $3.44M | Series A | – | – | |
| Apr 2026 | $3.44M | Series A | – | – | |
| Oct 2025 | $2.26M | Series A | – | – | |
| Apr 2024 | – | Seed | – | Real Tech Holdings, MTG Ventures |
13 investors in total: 13 institutional.
Investors in Illumi Medical
Illumi Medical has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Ogaki Kyoritsu Bank, UntroD and UntroD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in beauty, wellness, food, and sports tech. | – | mtgv.vc | Nagoya, Japan | |
Investments in deep tech and untrodden areas for societal impact. | 2015 | untrod.inc | Tokyo, Japan | |
A seed fund focused on regional startup investments in Japan. | 2022 | cjs.vc | Nagoya, Japan | |
- | – | okbcapital.co.jp | - | |
- | – | smbc-vc.co.jp | - | |
UntroD is focused on impact investments in deep tech innovations. | – | realtech.holdings | Tokyo, Japan | |
Commercial banking services including deposits and lending are provided. | 1896 | okb.co.jp | Ogaki, Japan | |
- | – | mintco.tcc.mode | - | |
- | – | meigin.com | - | |
- | – | hokkokubank.co.jp | - |
Investor details for Illumi Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Illumi Medical
3 dated milestones of Illumi Medical across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Illumi Medical is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $3.4M.
Competitors of Illumi Medical
Illumi Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, CranioVation, Adgero Biopharma, Lumeda and SpectraCure, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| photopharmics.com | 2011 | American Fork, United States | $43.44M | – | Non-invasive phototherapy for Parkinson's disease is developed. | |
| craniovation.com | 2017 | Rochester, United States | $7.61M | – | Minimally invasive devices for brain tumor treatment are provided. | |
| adgerobiopharm.com | 2012 | Princeton, United States | $5.52M | – | Photodynamic therapy for cutaneous metastatic breast cancer is developed. | |
| lumedainc.com | 2020 | Rocky Hill, United States | $5.34M | 10 | Photodynamic therapy device for lung cancer treatment is developed. | |
| spectracure.com | 2003 | Lund, Sweden | – | – | Developer of Interstitial photo dynamic therapy for solid tumours | |
| impactbiotech.com | 2022 | Ness Ziona, Israel | – | – | Developer of a drug delivery platform for the treatment of solid tumors | |
| photolitec.org | 2010 | Buffalo, United States | $5M | – | Supplies photosensitizing compounds for tumor imaging and photodynamic cancer therapy. | |
| illumacell.com | 2008 | Waterloo, Canada | – | – | Provider of medical light technology for photodynamic therapy cancer treatment | |
| incandotherapeutics.com | 2019 | Belmont, United States | – | – | Develops medical devices for glioblastoma therapy using wireless technology. |
Detailed competitors of Illumi Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Illumi Medical
The website of Illumi Medical (illumimedical.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 0.6% vs previous month
Latest news on Illumi Medical
Complete news archive for Illumi Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Illumi Medical
10 companies that operate in the same segment as Illumi Medical (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Illumi Medical
Illumi Medical was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Illumi Medical is headquartered in Nagoya, Japan. It is registered at Nagoya, Aichi, Japan.
Illumi Medical is a funded company, having raised a total of $9.13M across 4 funding rounds to date.
Illumi Medical was founded in 2023 in Nagoya, Japan, within the medical technology sector focused on oncology. An intravascular light irradiation system known as ET-BLIT is being developed to deliver targeted light to tissues affected by cancers including lung, pancreatic, and brain tumors. Operations center on advancing photodynamic therapy solutions for various cancer types, with research and development conducted in Japan.
Illumi Medical's top competitors include PhotoPharmics, ImPact Biotech and Adgero Biopharma.
Illumi Medical has 13 investors. Key investors include Ogaki Kyoritsu Bank, UntroD, UntroD, MTG Ventures, and Mintco.